Patients in the US with the ultra-rare disease WHIM syndrome now have their first approved treatment, after X4 Pharma’s Xolremdi was given a green light by the FDA. Oral CXCR4 antagonist Xolremdi ...
A good foundation sets the tone for everything that follows. Much like a nourishing moisturiser, the right formula will ensure all of your subsequent make-up falls perfectly into place. Get it wrong, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results